These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23020525)

  • 21. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
    Chen L; Yuan YF; Li Y; Chan TH; Zheng BJ; Huang J; Guan XY
    Gut; 2011 Apr; 60(4):534-43. PubMed ID: 21068133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
    Cai MY; Zhang B; He WP; Yang GF; Rao HL; Rao ZY; Wu QL; Guan XY; Kung HF; Zeng YX; Xie D
    Cancer Sci; 2010 Jun; 101(6):1543-9. PubMed ID: 20367640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Nesland JM; Berner A; Bryne M; Reich R
    Clin Exp Metastasis; 1999; 17(10):799-808. PubMed ID: 11089877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
    Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
    Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
    Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
    Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.
    Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
    Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
    Chan TH; Chen L; Liu M; Hu L; Zheng BJ; Poon VK; Huang P; Yuan YF; Huang JD; Yang J; Tsao GS; Guan XY
    Hepatology; 2012 Feb; 55(2):491-505. PubMed ID: 21953552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection.
    Hyeon J; Ahn S; Park CK
    Korean J Pathol; 2013 Feb; 47(1):9-15. PubMed ID: 23482400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients.
    Engelstaedter V; Heublein S; Schumacher AL; Lenhard M; Engelstaedter H; Andergassen U; Guenthner-Biller M; Kuhn C; Rack B; Kupka M; Mayr D; Jeschke U
    BMC Cancer; 2012 Dec; 12():600. PubMed ID: 23241107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
    Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
    Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
    Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
    Ann Oncol; 1999 Nov; 10(11):1335-41. PubMed ID: 10631462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CHD1L Promotes Neuronal Differentiation in Human Embryonic Stem Cells by Upregulating PAX6.
    Dou D; Zhao H; Li Z; Xu L; Xiong X; Wu X; Sun Y; Zeng S; Ouyang Q; Zhou D; Ma N; Lin G; Hu L
    Stem Cells Dev; 2017 Nov; 26(22):1626-1636. PubMed ID: 28946814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer.
    Motohara T; Fujimoto K; Tayama S; Narantuya D; Sakaguchi I; Tashiro H; Katabuchi H
    Obstet Gynecol; 2016 Jun; 127(6):1003-1011. PubMed ID: 27159753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
    Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
    Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas.
    Engqvist H; Parris TZ; Kovács A; Nemes S; Werner Rönnerman E; De Lara S; Biermann J; Sundfeldt K; Karlsson P; Helou K
    BMC Cancer; 2019 Sep; 19(1):928. PubMed ID: 31533654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.
    Yang GF; He WP; Cai MY; He LR; Luo JH; Deng HX; Guan XY; Zeng MS; Zeng YX; Xie D
    BMC Cancer; 2010 Apr; 10():133. PubMed ID: 20377880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
    Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
    J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The validation of new CHD1L inhibitors as a therapeutic strategy for cancer.
    Clune S; Awolade P; Zhou Q; Esquer H; Matter B; Kearns JT; Kellett T; Akintayo DC; Kompella UB; LaBarbera DV
    Biomed Pharmacother; 2024 Jan; 170():116037. PubMed ID: 38128184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.